EOLS

Handel nachbörslich: 5.85 0.20 +3.54%

Evolus Inc (EOLS)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

24-Stunden-Volumen:

Relative Volume:

Marktkapitalisierung:

Nettoeinkommen (Verlust:

Netto-Cashflow:

1W Leistung:

1M Leistung:

6M Leistung:

1J Leistung:

1-Tages-Spanne:

1-Wochen-Bereich:

52-Wochen-Spanne:

Evolus Inc Stock (EOLS) Company Profile

Healthcare (1115)

(949) 284-4555

520 NEWPORT CENTER DRIVE, NEWPORT BEACH

@evolusaesthetic

Nächster Verdiensttermin

Neueste SEC-Einreichungen

EOLS's Discussions on Twitter

Vergleichen Sie EOLS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
EOLS Evolus Inc	5.65	372.07M	202.09M	-61.69M	-35.64M	-1.08
ZTS Zoetis Inc	127.17	55.90B	9.40B	2.65B	2.24B	5.935
TAK Takeda Pharmaceutical Co Adr	16.31	51.72B	29.63B	260.53M	5.51B	0.0788
HLN Haleon Plc Adr	9.91	44.71B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	32.01	37.30B	16.88B	666.71M	251.19M	0.6132
RGC Regencell Bioscience Holdings Ltd	45.79	20.48B	0	-5.87M	-767.30K	-0.45

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-08-06	Herabstufung	Needham	Buy → Hold
2025-04-17	Eingeleitet	BTIG Research	Buy
2024-01-29	Hochstufung	Barclays	Equal Weight → Overweight
2022-06-23	Eingeleitet	Needham	Buy
2022-05-12	Hochstufung	Barclays	Underweight → Equal Weight
2022-01-20	Hochstufung	Truist	Hold → Buy
2021-05-06	Hochstufung	Mizuho	Neutral → Buy
2021-04-08	Bestätigt	H.C. Wainwright	Buy
2021-02-24	Herabstufung	Truist	Buy → Hold
2020-07-07	Herabstufung	Mizuho	Buy → Neutral
2020-02-06	Fortgesetzt	Mizuho	Buy
2019-11-26	Eingeleitet	SVB Leerink	Outperform
2019-09-05	Fortgesetzt	Mizuho	Buy
2019-06-28	Eingeleitet	Wells Fargo	Market Perform
2019-06-11	Eingeleitet	Barclays	Underweight
2019-03-20	Eingeleitet	SunTrust	Buy
2019-02-14	Eingeleitet	H.C. Wainwright	Buy
2019-01-29	Eingeleitet	Stifel	Buy

Alle ansehen

Evolus Inc Aktie (EOLS) Neueste Nachrichten

Finanzdaten der Evolus Inc-Aktie (EOLS)

Evolus Inc (EOLS)

Evolus Inc Stock (EOLS) Company Profile

Vergleichen Sie EOLS mit anderen Aktien

Evolus Inc Stock (EOLS) Upgrades & Downgrades

Evolus Inc Aktie (EOLS) Neueste Nachrichten

Evolus sees FY26 revenue $327M-$337M, consensus $351.66M - TipRanks

Evolus sees Q4 revenue $88.6M-$90.6M, consensus $90.91M - TipRanks

Evolus, Inc. (EOLS) Stock Analysis: Unpacking a 222% Potential Upside in the Aesthetic Market - DirectorsTalk Interviews

EOLS: HC Wainwright & Co. Reiterates Buy Rating with $20 Price T - GuruFocus

Evolus (EOLS) Projects Strong Revenue Growth Through 2028 - GuruFocus

Evolus (EOLS) Achieves Sixth Year of Double-Digit Growth in 2025 - GuruFocus

EOLS Projects Optimistic Growth with Strategic Market Expansion - GuruFocus

Evolus outlook FY sales USD 327-337 million - MarketScreener

Evolus reports 15% Q4 growth, projects 2026 profitability By Investing.com - Investing.com India

How Evolus Inc. stock valuations compare to rivalsMarket Growth Review & Stock Timing and Entry Methods - ulpravda.ru

Does Evolus Inc. stock trade at a discount to peersChart Signals & Reliable Breakout Forecasts - ulpravda.ru

Why Evolus Inc. stock is favored by top institutions2025 Performance Recap & Expert Curated Trade Setup Alerts - ulpravda.ru

Can Evolus Inc. stock deliver strong Q4 earningsSwing Trading Ideas & Small Budget Portfolio Growth - ulpravda.ru

Insider Sellers Might Regret Selling Evolus Shares at a Lower Price Than Current Market Value - simplywall.st

Mizuho cuts Evolus (EOLS) estimates for Jeuveau/Evolysse on waning consumer sentiment and inflationary pressure on elective aesthetics - MSN

Will Evolus Inc. (EVL) stock benefit from sector leadershipRisk Mitigation Techniques & Low Entry Cost Investments - ulpravda.ru

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR) and Evolus (EOLS) - The Globe and Mail

Discipline and Rules-Based Execution in EOLS Response - Stock Traders Daily

Avelar Rui, Evolus officer, sells $16k in EOLS stock By Investing.com - Investing.com South Africa

Evolus CEO Moatazedi sells $75k in shares By Investing.com - Investing.com South Africa

Evolus CEO Moatazedi sells $75k in shares - Investing.com

Avelar Rui, Evolus officer, sells $16k in EOLS stock - Investing.com

Insider Selling: Evolus (NASDAQ:EOLS) Insider Sells 10,539 Shares of Stock - MarketBeat

Rui Avelar Sells 2,261 Shares of Evolus (NASDAQ:EOLS) Stock - MarketBeat

ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away - The Motley Fool

Evolus, Inc. $EOLS Shares Acquired by Rice Hall James & Associates LLC - MarketBeat

Big Picture: Does Evolus Inc stock trade at a discount to peersPortfolio Update Summary & AI Powered Buy and Sell Recommendations - moha.gov.vn

Evolus' (EOLS) "Hold" Rating Reaffirmed at Needham & Company LLC - MarketBeat

Needham Reiterates Evolus (EOLS) Hold Recommendation - Nasdaq

Needham Reiterates Hold Rating for Evolus (EOLS) | EOLS Stock Ne - GuruFocus

Assenagon Asset Management S.A. Trims Position in Evolus, Inc. $EOLS - MarketBeat

Net current asset value per share of Evolus, Inc. – BER:EVL - TradingView — Track All Markets

Trading the Move, Not the Narrative: (EOLS) Edition - Stock Traders Daily

EV Market: Why Evolus Inc. stock is a must watch in 2025Earnings Growth Summary & Consistent Return Investment Signals - Улправда

Midday Stock Roundup: Rivian Stock Continues to Climb - Orange County Business Journal

Why Evolus Inc. stock is rated strong buyTrade Risk Summary & Consistent Profit Trading Strategies - DonanımHaber

Will Evolus Inc. stock continue dividend increasesJuly 2025 Spike Watch & Capital Efficient Trade Techniques - DonanımHaber

Why Evolus Inc. stock is a must watch in 2025Insider Selling & Precise Trade Entry Recommendations - Улправда

Can Evolus Inc. stock beat market expectations this quarterGlobal Markets & Daily Chart Pattern Signals - Улправда

Evolus: A Difficult 2025 Means I'm Downgrading Stock To 'Hold' For 2026 (NASDAQ:EOLS) - Seeking Alpha

Evolus, Inc. (NASDAQ:EOLS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat

Mizuho Cuts Evolus (EOLS) Estimates for Jeuveau/Evolysse on Waning Consumer Sentiment and Inflationary Pressure on Elective Aesthetics - Insider Monkey

20 Stocks That Will Double in 2026 - Insider Monkey

2,435,550 Shares in Evolus, Inc. $EOLS Bought by Frazier Life Sciences Management L.P. - MarketBeat

Midday Stock Roundup: Rivian Rises on Chip, Models - Orange County Business Journal

Frontier Capital Management Co. LLC Buys 457,533 Shares of Evolus, Inc. $EOLS - MarketBeat

Evolus, Inc. Earnings Call Highlights Growth and Resilience - MSN

Jump Financial LLC Grows Stock Position in Evolus, Inc. $EOLS - MarketBeat

Mizuho reaffirms Evolus stock rating at Outperform amid early signs of market stabilization - Investing.com Canada

Evolus Navigates a Path to Profitability Amidst Quarterly Challenges - AD HOC NEWS

Finanzdaten der Evolus Inc-Aktie (EOLS)

Umsatz

Nettogewinn

Free Cashflow

ENV

Ähnlich wie EOLS